Breaking News Instant updates and real-time market news.

AGN

Allergan

$204.65

1.99 (0.98%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30

Allergan announces new $2B share repurchase plan

  • 25

    Sep

AGN Allergan
$204.65

1.99 (0.98%)

09/20/17
SBSH
09/20/17
NO CHANGE
Target $280
SBSH
Buy
Allergan pipeline largely out of the shares, says Citi
Citi analyst Liav Abraham believes Allergan's pipeline remains largely out of the share price. In a research not titled "Emerging from the Twilight Zone. Reiterating Buy Rating," the analyst admits the outcome of the Restasis district court litigation remains a near-term overhang on the stock. She believes, however, that Allergan's pipeline will become a "more meaningful part of the debate heading into 2018." The company's nonalcoholic steatohepatitis opportunity, as well as its migraine assets, could generate $3B in peak non-risk-adjusted sales, which is largely not discounted in the current valuation, Abraham contends. She lowered her price target for Allergan shares to $280 from $290 and keeps a Buy rating on the name.
09/20/17
MSCO
09/20/17
DOWNGRADE
MSCO
Equal Weight
Allergan downgraded to Equal Weight from Overweight at Morgan Stanley
09/20/17
09/20/17
DOWNGRADE
Target $228

Equal Weight
Allergan cut to Equal Weight on lower margin assumptions at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger downgraded Allergan to Equal Weight from Overweight, explaining that he previously projected growth above the average of its Major Pharma peers, but he now has less conviction in its pipeline catalysts, sees more Restasis patent risk and he no longer expects margin expansion because high gross margin products face generic pressures. The analyst lowered his longer-term margin assumptions for Allergan and cut his price target on the stock to $228 from $284.
09/22/17
WELS
09/22/17
NO CHANGE
Target $276
WELS
Outperform
Allergan trial not successful, but overhang removed, says Wells Fargo
Wells Fargo analyst David Maris says the best he can say about Allergan's data today for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis is that Cenicriviroc "seems safe and it may have a benefit in some patients." Overall, the study was not a success, but the good safety and other data support further study, Maris tells investors in a research note titled "Data Mixed, One Overhang Gone." The analyst keeps an Outperform rating on Allergan shares with a $276 price target.

TODAY'S FREE FLY STORIES

IBKC

Iberiabank

$83.10

-1.2 (-1.42%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Hot Stocks
Federal Reserve approves Iberiabank purchase of Gibraltar Private Bank »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZN

Zion Oil & Gas

$4.47

0.43 (10.64%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Periodicals
Zion Oil & Gas shares deserve 'to crater,' TheStreetSweeper says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

, LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

12:07
02/21/18
02/21
12:07
02/21/18
12:07
Hot Stocks
Lionsgate slides as analyst cuts rating on competitive, cost concerns »

Bernstein analyst Todd…

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

DIS

Disney

$106.29

0.31 (0.29%)

FOX

21st Century Fox

$36.61

-0.43 (-1.16%)

FOXA

21st Century Fox

$37.13

-0.33 (-0.88%)

CMCSA

Comcast

$39.47

-0.32 (-0.80%)

CMCSK

Comcast

T

AT&T

$36.82

0.047 (0.13%)

TWX

Time Warner

$95.48

0.405 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 20

    Mar

  • 23

    Apr

ATVI

Activision Blizzard

$70.84

0.65 (0.93%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Periodicals
Activision's Sledgehammer founders leave studio, Kotaku reports »

Michael Condrey and Glen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

UNP

Union Pacific

$133.54

3.31 (2.54%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Hot Stocks
Union Pacific backs Q1 and FY18 volume goal of slightly positive »

Comments were made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TXN

Texas Instruments

$105.29

0.82 (0.78%)

12:01
02/21/18
02/21
12:01
02/21/18
12:01
Conference/Events
Texas Instruments management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 30

    May

BHGE

Baker Hughes

$27.48

1.04 (3.93%)

12:00
02/21/18
02/21
12:00
02/21/18
12:00
Options
Baker Hughes calls active as shares rally »

Baker Hughes calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

12:00
02/21/18
02/21
12:00
02/21/18
12:00
General news
FOMC minutes preview: »

FOMC minutes preview: the…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:55
02/21/18
02/21
11:55
02/21/18
11:55
Hot Stocks
Campbell expects $170M in cost synergies from Snyder's-Lance deal by FY22 »

CFO Anthony DiSilvestro…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

HBAN

Huntington Bancshares

$15.90

0.07 (0.44%)

11:50
02/21/18
02/21
11:50
02/21/18
11:50
Options
Call buyers in Huntington Bancshares »

Call buyers in Huntington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

11:50
02/21/18
02/21
11:50
02/21/18
11:50
General news
Treasury $15 B 2-year FRN reopening was weak »

Treasury $15 B 2-year FRN…

C

Citi

$77.50

1.0399 (1.36%)

11:47
02/21/18
02/21
11:47
02/21/18
11:47
Periodicals
Citi creates new position to supervise EMEA commodities banking, FT says »

According to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

, XLF

Financial Select Sector

$29.21

0.32 (1.11%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Technical Analysis
Technical Take: S&P 500 hits session highs at midday »

At time of writing the…

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

XLF

Financial Select Sector

$29.21

0.32 (1.11%)

XLB

S&P Select Materials SPDR

$60.73

0.52 (0.86%)

XLK

Technology Select Sector SPDR

$67.79

0.55 (0.82%)

XLRE

Real Estate SPDR

$30.23

-0.145 (-0.48%)

XLP

Consumer Staples Sector SPDR

$54.16

-0.18 (-0.33%)

SPY

SPDR S&P 500 ETF Trust

$273.35

1.945 (0.72%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

SLCA

U.S. Silica

$26.56

-4.195 (-13.64%)

11:40
02/21/18
02/21
11:40
02/21/18
11:40
Options
Buy the dip call activity in Silica Holdings as shares tumble on earnings »

Buy the dip call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Hot Stocks
Campbell expects Snyder's-Lance deal to deliver 'significant' cost synergies »

Says Snyder's-Lance…

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

PCRX

Pacira

$31.25

1.1 (3.65%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Recommendations
Pacira analyst commentary  »

Pacira Q4 sales momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Apr

AIDIF

Air Canada

11:35
02/21/18
02/21
11:35
02/21/18
11:35
Conference/Events
Air Canada management to meet with RBC Capital »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Options
25K Alerian MLP Mar 9th 10.5 puts trade for 20c on ISE »

25K Alerian MLP Mar 9th…

CPB

Campbell Soup

$45.38

-0.7 (-1.52%)

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Hot Stocks
Campbell Soup says goal is to become leading health and well-being food company »

President and CEO Denise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

PERY

Perry Ellis

$26.32

-0.52 (-1.94%)

11:28
02/21/18
02/21
11:28
02/21/18
11:28
Hot Stocks
Perry Ellis announces mens underwear, loungewear license in South Korea »

Earlier today, Perry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$29.48

0.36 (1.24%)

11:27
02/21/18
02/21
11:27
02/21/18
11:27
Recommendations
Noble Energy analyst commentary  »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

DVN

Devon Energy

$32.86

-1.79 (-5.17%)

11:26
02/21/18
02/21
11:26
02/21/18
11:26
Hot Stocks
Devon Energy CEO confident that investor returns will increase in FY18 »

Devon Energy CEO David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.